Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy.

Tytuł:
Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy.
Autorzy:
Rossino MG; Department of Biology, University of Pisa, 56126 Pisa, Italy.
Lulli M; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, 50134 Florence, Italy.
Amato R; Department of Biology, University of Pisa, 56126 Pisa, Italy.
Cammalleri M; Department of Biology, University of Pisa, 56126 Pisa, Italy.; Interdepartmental Research Center Nutrafood 'Nutraceuticals and Food for Health', University of Pisa, 56124 Pisa, Italy.
Monte MD; Department of Biology, University of Pisa, 56126 Pisa, Italy.; Interdepartmental Research Center Nutrafood 'Nutraceuticals and Food for Health', University of Pisa, 56124 Pisa, Italy.
Casini G; Department of Biology, University of Pisa, 56126 Pisa, Italy.; Interdepartmental Research Center Nutrafood 'Nutraceuticals and Food for Health', University of Pisa, 56124 Pisa, Italy.
Źródło:
Cells [Cells] 2020 Jun 11; Vol. 9 (6). Date of Electronic Publication: 2020 Jun 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI
MeSH Terms:
Autocrine Communication*/drug effects
Oxidative Stress*/drug effects
Diabetic Retinopathy/*metabolism
Diabetic Retinopathy/*pathology
Retina/*metabolism
Retina/*pathology
Vascular Endothelial Growth Factor A/*metabolism
Animals ; Cell Line ; Cell Nucleus/drug effects ; Cell Nucleus/metabolism ; Culture Media, Conditioned/pharmacology ; Diabetic Retinopathy/genetics ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Mice, Inbred C57BL ; Models, Biological ; NF-E2-Related Factor 2/metabolism ; Protein Transport/drug effects ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Vascular Endothelial Growth Factor A/genetics ; Vascular Endothelial Growth Factor Receptor-2/metabolism
References:
J Neurochem. 2012 Mar;120(5):818-29. (PMID: 22168912)
Redox Biol. 2018 Oct;19:401-411. (PMID: 30241031)
Drug Discov Today. 2019 Aug;24(8):1483-1498. (PMID: 30731239)
Exp Eye Res. 2006 Sep;83(3):473-83. (PMID: 16750526)
Theranostics. 2018 Sep 09;8(17):4695-4709. (PMID: 30279732)
Front Neurosci. 2019 Nov 08;13:1172. (PMID: 31787868)
Oncogene. 1999 Feb 25;18(8):1619-27. (PMID: 10102632)
Diabetes. 2015 Oct;64(10):3554-63. (PMID: 26068541)
Nat Rev Neurol. 2016 Aug;12(8):439-54. (PMID: 27364743)
J Diabetes Res. 2016;2016:9508541. (PMID: 27123463)
Mol Vis. 2013;19:281-91. (PMID: 23401656)
Mol Cancer Res. 2014 Aug;12(8):1100-11. (PMID: 24759089)
Cell Res. 2014 Sep;24(9):1121-36. (PMID: 25145356)
J Cell Biol. 2006 Aug 14;174(4):593-604. (PMID: 16893970)
Expert Opin Biol Ther. 2018 Dec;18(12):1257-1270. (PMID: 30408422)
FASEB J. 2003 Aug;17(11):1562-4. (PMID: 12824281)
Vision Res. 2017 Oct;139:108-114. (PMID: 28601428)
PLoS One. 2008;3(11):e3554. (PMID: 18978936)
Prog Retin Eye Res. 2008 Jul;27(4):331-71. (PMID: 18653375)
Nutrients. 2018 Dec 05;10(12):. (PMID: 30563182)
Curr Diabetes Rev. 2017;13(2):161-174. (PMID: 27748176)
PLoS One. 2018 Aug 28;13(8):e0202039. (PMID: 30153269)
Transl Res. 2015 Jun;165(6):641-50. (PMID: 25553605)
J Biol Chem. 2011 Dec 16;286(50):42863-72. (PMID: 22033923)
J Korean Med Sci. 2002 Oct;17(5):581-8. (PMID: 12378005)
Int J Mol Sci. 2018 Jun 20;19(6):. (PMID: 29925789)
Cancer Biol Ther. 2014;15(11):1479-88. (PMID: 25482945)
Nutrients. 2019 Apr 02;11(4):. (PMID: 30987058)
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1190-7. (PMID: 19834034)
J Cell Sci. 2016 Nov 1;129(21):4091-4104. (PMID: 27656109)
J Diabetes Res. 2015;2015:582060. (PMID: 26137497)
Antioxid Redox Signal. 2018 Dec 10;29(17):1727-1745. (PMID: 28899199)
Leukemia. 2011 Oct;25(10):1533-42. (PMID: 21637285)
Exp Eye Res. 2017 Jul;160:1-10. (PMID: 28419863)
ACS Chem Biol. 2016 Nov 18;11(11):3214-3225. (PMID: 27552339)
Exp Eye Res. 2020 Feb;191:107903. (PMID: 31904361)
Br J Dermatol. 2014 Jan;170(1):78-86. (PMID: 24033364)
Curr Cancer Drug Targets. 2013 Mar;13(3):245-51. (PMID: 23297826)
Free Radic Biol Med. 2015 Nov;88(Pt B):101-107. (PMID: 26057936)
Pharmacol Res. 2015 Sep;99:137-48. (PMID: 26054568)
J Pathol. 2012 Feb;226(3):519-33. (PMID: 21960021)
Oncotarget. 2017 Aug 4;8(40):69139-69161. (PMID: 28978186)
Mol Cancer Ther. 2008 Jun;7(6):1551-61. (PMID: 18566226)
Cancer Drug Resist. 2019 Sep 19;2(3):490-515. (PMID: 35582567)
Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3066-76. (PMID: 27286364)
Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1395-401. (PMID: 16899768)
Sci Rep. 2016 Nov 21;6:37338. (PMID: 27869147)
Adv Exp Med Biol. 2018;1074:473-478. (PMID: 29721978)
Int J Mol Sci. 2018 Mar 22;19(4):. (PMID: 29565290)
Naunyn Schmiedebergs Arch Pharmacol. 2011 Jun;383(6):593-612. (PMID: 21523559)
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3657-3663. (PMID: 31478766)
Curr Neuropharmacol. 2018;16(7):993-1003. (PMID: 28714394)
Oncotarget. 2014 Nov 30;5(22):10976-96. (PMID: 25428918)
Cell. 2007 Aug 24;130(4):691-703. (PMID: 17719546)
Adv Exp Med Biol. 2014;801:275-81. (PMID: 24664708)
Free Radic Biol Med. 2017 Feb;103:155-164. (PMID: 28012783)
J Biol Chem. 2008 Apr 25;283(17):11435-44. (PMID: 18305118)
Contributed Indexing:
Keywords: HIF-1; MIO-M1; Müller cell; Nrf2; VEGFR2; conditioned medium; diabetic retinopathy; retinal explant
Substance Nomenclature:
0 (Culture Media, Conditioned)
0 (Hypoxia-Inducible Factor 1, alpha Subunit)
0 (NF-E2-Related Factor 2)
0 (RNA, Messenger)
0 (Vascular Endothelial Growth Factor A)
EC 2.7.10.1 (Vascular Endothelial Growth Factor Receptor-2)
Entry Date(s):
Date Created: 20200618 Date Completed: 20210302 Latest Revision: 20240329
Update Code:
20240329
PubMed Central ID:
PMC7349409
DOI:
10.3390/cells9061452
PMID:
32545222
Czasopismo naukowe
Background: Oxidative stress (OS) plays a central role in diabetic retinopathy (DR), triggering expression and release of vascular endothelial growth factor (VEGF), the increase of which leads to deleterious vascular changes. We tested the hypothesis that OS-stimulated VEGF induces its own expression with an autocrine mechanism.
Methods: MIO-M1 cells and ex vivo mouse retinal explants were treated with OS, with exogenous VEGF or with conditioned media (CM) from OS-stressed cultures.
Results: Both in MIO-M1 cells and in retinal explants, OS or exogenous VEGF induced a significant increase of VEGF mRNA, which was abolished by VEGF receptor 2 (VEGFR-2) inhibition. OS also caused VEGF release. In MIO-M1 cells, CM induced VEGF expression, which was abolished by a VEGFR-2 inhibitor. Moreover, the OS-induced increase of VEGF mRNA was abolished by a nuclear factor erythroid 2-related factor 2 (Nrf2) blocker, while the effect of exo-VEGF resulted Nrf2-independent. Finally, both the exo-VEGF- and the OS-induced increase of VEGF expression were blocked by a hypoxia-inducible factor-1 inhibitor.
Conclusions: These results are consistent with the existence of a retinal VEGF autocrine loop triggered by OS. This mechanism may significantly contribute to the maintenance of elevated VEGF levels and therefore it may be of central importance for the onset and development of DR.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies